Literature DB >> 15084147

Transferrin receptor 2 protein is not expressed in normal erythroid cells.

Alessia Calzolari1, Silvia Deaglio, Nadia Maria Sposi, Eleonora Petrucci, Ornella Morsilli, Marco Gabbianelli, Fabio Malavasi, Cesare Peschle, Ugo Testa.   

Abstract

Human TFR2 (transferrin receptor 2) is a membrane-bound protein homologous with TFR1. High levels of TFR2 mRNA were found mainly in the liver and, to a lesser extent, in erythroid precursors. However, although the presence of the TFR2 protein in hepatic cells has been confirmed in several studies, evidence is lacking about the presence of the TFR2 protein in normal erythroid cells. Using two anti-TFR2 monoclonal antibodies, G/14C2 and G/14E8, we have provided evidence that TFR2 protein is not expressed in normal erythroid cells at any stage of differentiation, from undifferentiated CD34+ cells to mature orthochromatic erythroblasts. In contrast, erythroleukaemic cells (K562 cells) exhibited a high level of expression of TFR2 at both the mRNA and the protein level. We can therefore conclude that an elevated expression of TFR2 protein is observed in leukaemic cells, but not in normal erythroblasts. The implications of this observation for the understanding of the phenotypic features of haemochromatosis due to mutation of the TFR2 gene are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084147      PMCID: PMC1133871          DOI: 10.1042/BJ20040230

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.

Authors:  Ida Casella; Tiziana Feccia; Cristiana Chelucci; Paola Samoggia; Germana Castelli; Raffaella Guerriero; Isabella Parolini; Eleonora Petrucci; Elvira Pelosi; Ornella Morsilli; Marco Gabbianelli; Ugo Testa; Cesare Peschle
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

2.  Regulation of expression of murine transferrin receptor 2.

Authors:  H Kawabata; R S Germain; T Ikezoe; X Tong; E M Green; A F Gombart; H P Koeffler
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

3.  Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.

Authors:  H Kawabata; T Nakamaki; P Ikonomi; R D Smith; R S Germain; H P Koeffler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

4.  Mechanisms of differential transferrin receptor expression in normal hematopoiesis.

Authors:  N M Sposi; L Cianetti; E Tritarelli; E Pelosi; S Militi; T Barberi; M Gabbianelli; E Saulle; L Kühn; C Peschle; U Testa
Journal:  Eur J Biochem       Date:  2000-12

5.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1.

Authors:  R De Maria; A Zeuner; A Eramo; C Domenichelli; D Bonci; F Grignani; S M Srinivasula; E S Alnemri; U Testa; C Peschle
Journal:  Nature       Date:  1999-09-30       Impact factor: 49.962

6.  Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis.

Authors:  Robert E Fleming; John R Ahmann; Mary C Migas; Abdul Waheed; H Phillip Koeffler; Hiroshi Kawabata; Robert S Britton; Bruce R Bacon; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

7.  Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.

Authors:  Silvia Deaglio; Andrea Capobianco; Angelita Calì; Francesca Bellora; Federica Alberti; Luisella Righi; Anna Sapino; Clara Camaschella; Fabio Malavasi
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

8.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.

Authors:  C Camaschella; A Roetto; A Calì; M De Gobbi; G Garozzo; M Carella; N Majorano; A Totaro; P Gasparini
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

9.  New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.

Authors:  A Roetto; A Totaro; A Piperno; A Piga; F Longo; G Garozzo; A Calì; M De Gobbi; P Gasparini; C Camaschella
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

10.  Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene.

Authors:  Domenico Girelli; Claudia Bozzini; Antonella Roetto; Federica Alberti; Filomena Daraio; Romano Colombari; Oliviero Olivieri; Roberto Corrocher; Clara Camaschella
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

View more
  4 in total

1.  Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.

Authors:  Martha B Johnson; Juxing Chen; Nicholas Murchison; Frank A Green; Caroline A Enns
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

2.  Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family.

Authors:  Lisa Ann Lambert; Stacey L Mitchell
Journal:  J Mol Evol       Date:  2006-12-09       Impact factor: 2.395

3.  Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.

Authors:  Anita C G Chua; Roheeth D Delima; Evan H Morgan; Carly E Herbison; Janina E E Tirnitz-Parker; Ross M Graham; Robert E Fleming; Robert S Britton; Bruce R Bacon; John K Olynyk; Debbie Trinder
Journal:  J Hepatol       Date:  2010-01-06       Impact factor: 25.083

Review 4.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.